Representation in Clinical Trials

Research institutions have long struggled with accurate population representation in clinical trials. The growing proliferation of digital in healthcare ecosystems makes this more likely, but it is not perfect. UCLA Health’s Dr. Arash Naeim and Dr. Medell Briggs-Malonson share their efforts to progress the intersectionality of health technology and health audience in clinical trials and beyond. Verizon’s Robin Goldsmith and Ned Chini round out this conversation with the role devices and connectivity play in achieving representation.

Recent Episodes

Brent speaks with Day-Vene Gilliam, VP of National Network Optimization & Business Development at Elevance Health, about how Anthem is evolving its network strategy to deliver greater value to clients and members. From expanding value-based care contracts with over 650,000 providers to leveraging digital tools like HealthOS for real-time data and gap-closure, Anthem is enabling…

Dr. Kofi Essel, community pediatrician and Elevance Health’s Food as Medicine Director, joins Brent to discuss how nutrition is becoming a central lever in both preventing and treating chronic disease. With millions of Americans living with diabetes, hypertension, and obesity, Dr. Essel explains how Elevance is building interventions that help members access high-quality food and…

Dr. Sam Ambewadikar returns to break down Anthem’s Whole Health Index (WHI)—a powerful tool that distills medical, social, environmental, and behavioral data into a single score (0–100) to identify members most at risk. By surfacing factors like transportation deserts, housing instability, or food insecurity, WHI enables Anthem care managers and advocates to proactively match members…